Le Lézard
Classified in: Health, Business
Subject: CON

Apotex Focuses on High Growth Markets with Sale of European Generics Business



Sale Part of Previously Announced Plan to Assess Global Footprint

TORONTO, July 14, 2018 /CNW/ - Apotex, Canada's largest generic pharmaceutical company, has signed an agreement to sell its commercial operations and certain supporting infrastructure for its generics business in five European countries to Aurobindo Pharma Limited.  The sale will allow Apotex to focus its resources on the Americas where strong demand for its portfolio continues.

"This is a positive move for our organization and enables us to further accelerate our efforts to drive additional growth in the Americas, while also creating manufacturing capacity to meet growing demand," said Jeff Watson, President & Chief Operating Officer, Apotex.

Apotex operates its European generic pharmaceutical business through wholly-owned subsidiaries in the Netherlands, Poland, the Czech Republic, Spain and Belgium.  Pursuant to the Agreement, these subsidiaries will be sold and certain supporting infrastructure including personnel, products, marketing authorizations and dossier license rights regarding the pharmaceutical business in those countries will effectively be transferred to Aurobindo Pharma Limited, once all closing conditions, which include customary competition clearance, are satisfied.

As part of the agreement, Apotex also entered into a transitional manufacturing and supply arrangement in order to support the ongoing growth plans of these businesses.

Apotex is a Canadian based, global pharmaceutical company, employing over 10,000 people in research, development, manufacturing and distribution facilities worldwide. Apotex is a vertically integrated business that includes generic medicines, biosimilars, active pharmaceutical ingredients and innovative pharmaceuticals. It produces more than 300 generic molecules in approximately 4,000 different dosages. For more information, please visit http://www.apotex.com

SOURCE Apotex Inc.


These press releases may also interest you

at 04:15
Discovery and the European Tour have announced a new partnership that will see GOLFTV continue to expand its portfolio and move towards becoming the established 'digital home of golf' for fans around the world.  The wide-ranging agreement includes...

at 04:12
Pintec Technology Holdings Ltd. ("PINTEC") , a leading independent technology platform enabling financial services in China, today announced its cooperation with Zhejiang Rural Credit Cooperatives on intelligent wealth management innovations....

at 04:10
VEON Holdings B.V. (the "Company"), a wholly-owned subsidiary of VEON Ltd. ("VEON"), and VIP Finance Ireland DAC (in respect of the 2021 Notes (as defined below) only), announce today an extension of the Expiration Time and the Voting Deadline (each...

at 04:00
MiX Telematics, a leading global provider of fleet and asset management solutions, is proud to announce that it has been selected by a large dairy company in Brazil to help address their safety, security, efficiency and compliance needs. As one of...

at 04:00
Third Bridge, a leading research firm serving investment companies, has again been recognised as one of Britain's 100 fastest growing companies by The Sunday Times Virgin Atlantic Fast Track 100. The inclusion marks the third consecutive year Third...

at 04:00
VERMEG the banking and insurance software solution leader has announced today that Australian Challenger bank, Judo Capital have selected VERMEG's AgileREPORTER package, to meet its' Australian Prudential Regulation Authority (APRA) reporting...




News published on 14 july 2018 at 01:00 and distributed by: